fosbretabulin

DRUG5 trials

Sponsors

Mateon Therapeutics, The Christie NHS Foundation Trust, Lowell Anthony, MD

Conditions

EverolimusNeoplasms, OvarianNeuroendocrine TumorsOvarian CancerOvarian NeoplasmsPolypoidal Choroidal VasculopathyTumors

Phase 1

PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer

TerminatedNCT02055690

The Christie NHS Foundation TrustNeoplasms, Ovarian, Ovarian Cancer, Ovarian Neoplasms

Start: 2014-09-30End: 2017-11-24Updated: 2021-05-17

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

TerminatedNCT03014297

Lowell Anthony, MDEverolimus, Neuroendocrine Tumors

Start: 2017-03-06End: 2018-11-16Updated: 2019-08-08

Phase 2

A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer

CompletedNCT00653939

Mateon TherapeuticsTumors

Start: 2008-03-31End: 2011-10-31Updated: 2015-02-09

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

CompletedNCT01023295

Mateon TherapeuticsPolypoidal Choroidal Vasculopathy

Start: 2009-07-31End: 2010-08-31Updated: 2011-11-01

Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study

CompletedNCT02279602

Mateon TherapeuticsNeuroendocrine Tumors

Start: 2014-12-31End: 2016-08-31Updated: 2018-04-17

Related Papers

A phase I/II study of fosbretabulin in combination with everolimus in neuroendocrine tumors that have progressed after at least one prior regimen for metastatic disease.

Journal of Clinical Oncology2018-05-204 citations

The development and use of vascular targeted therapy in ovarian cancer.

2017-02-2465 citations